Picture of Synairgen logo

SNG Synairgen Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Synairgen, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.1-4.79-17.7-57.9-20.1
Depreciation
Amortisation
Non-Cash Items0.0620.0870.1980.4950.712
Other Non-Cash Items
Changes in Working Capital0.1711.65-6.5416.24.99
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-3.82-2.9-23.8-41-14.3
Capital Expenditures-0.386-0.01-0.076-0.033-0.006
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1.980.0760.0310.012-3.61
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities1.590.066-0.045-0.021-3.62
Financing Cash Flow Items-0.2090-3.2-0.0020
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.67096.4-0.1120.001
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.439-2.8372.5-41.1-17.9